VET
Thuốc thú y Trung ương Navetco ·UPCOM ·2026Q1
▲ Showing improvement
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, VET posted a sharp profit increase versus the same period, suggesting a clear improvement from a low base — this marks a reversal from the difficult phase before. However, profit is significantly supported by non-core sources and operating cash flow is not yet positive — the improvement signal needs more time to confirm.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.0 | 102.7 | 56.4 | 90.4 | 56.1 | 124.2 | 93.8 | 107.7 | 45.6 | 133.6 | 102.3 | 139.7 |
| Growth | -50% | +82% | -38% | +61% | -55% | +32% | -13% | +136% | -66% | +31% | -27% | — |
| Net Income | 0.8 | 4.8 | 4.4 | 7.9 | 0.4 | -48.2 | 1.8 | 6.5 | 1.8 | 9.1 | 10.7 | 11.8 |
| Net Margin | 1.49% | 4.65% | 7.78% | 8.78% | 0.76% | -38.79% | 1.96% | 6.07% | 3.96% | 6.85% | 10.44% | 8.42% |
Drivers of VET's profit
Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by lower selling expenses. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE rose from -12.2% to 5.8% — mainly driven by net margin, despite asset turnover and leverage moving in the opposite direction.
Is the profit sustainable?
Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.
What is driving the margin?
Net margin expanded to 5.94%, rising 16.3pp. Core operating signals are improving as SG&A / Revenue fell 8.3pp are enough to offset pressure from Gross margin fell 1.7pp (in addition, Other profit / Revenue rose 11.5pp added support while Net financial result / Revenue fell 1.6pp remained a drag).
Margin improves from both core operations and non-core items — the core foundation is positive, but the sustainability of non-core contributions needs monitoring.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Watchpoints
Financial result accounts for 42.4% of PBT and lifted net margin by 9.8pp — separate the operating contribution from this source.
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Capital structure is balanced — liabilities at 1.45x equity, net debt at 0.98x equity.
Inventory ended the period at 395.1bn, roughly 50.5% of total assets.
Over the last 12 months, working capital absorbed 67.8bn of cash, mainly because of higher receivables and lower payables. Part of that drag was offset by lower inventories.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
The inventory build-up noted above is reflected in a longer cash cycle. Cash conversion cycle lengthened by 180.1 days versus the same period last year. The main moves came from DIO rose 143.2 days, DSO rose 26.3 days, and DPO fell 10.7 days.
All 3 drivers are deteriorating — working capital is becoming more deeply tied up in the operating cycle.
Watchpoints
CCC stands at 844.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +26.3 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Check leverage, liquidity, and cash-flow conversion.
Leverage & Liquidity
Leverage warrants monitoring, with net debt / equity at 0.98x and interest coverage only at 1.08x.
At present, short-term debt accounts for 36.4% of total debt, cash equals 1.3% of debt, and total debt stands at 316.8bn.
Watchpoints
Interest coverage is 1.08x, leaving limited room to absorb financing costs.
Cash / debt stands at 1.3%, leaving limited liquidity buffer to monitor.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
Operating cash flow reached -17.3bn in 2025, against investing cash flow of 3.2bn.
Post-investment cash flow was negative +14.0bn. Financing cash flow was positive +14.5bn.
CFO / net income was -0.71x.
Track how much investment can be funded internally from operating cash flow.
Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with leverage and liquidity remaining the main constraint, with interest coverage at 1.08x. The next watchpoint is the earnings mix, when non-core contribution is -53.4%. The main offsetting support comes from operating efficiency, with net margin improving 16.3 pp.
Improvement: operating efficiency is getting better, with trailing-12M net margin at 5.94% after expanding 16.3pp versus the same period last year.
Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for -53.4% of PBT and CFO / net income currently at -0.71x.
Key risk: leverage and liquidity still require discipline, with interest coverage only at 1.08x.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
305.7 | 371.3 | 412.6 | 460.7 | 607.4 |
|
Cost of Goods Sold
|
183.3 | 206.6 | 232.7 | 256.0 | 0.0 |
|
Gross Profit
|
122.4 | 164.6 | 179.9 | 204.7 | 224.0 |
|
Financial Expenses
|
13.1 | 8.9 | 8.7 | 4.2 | -2.3 |
|
Selling Expenses
|
46.3 | 105.3 | 77.6 | 75.0 | -91.6 |
|
General and Administrative Expenses
|
56.7 | 53.5 | 60.1 | 69.0 | -36.7 |
|
Operating Profit
|
6.3 | -3.0 | 34.7 | 58.9 | 94.7 |
|
Profit Before Tax
|
18.2 | -39.6 | 36.2 | 66.6 | 88.5 |
|
Net Income
|
18.2 | -39.6 | 28.6 | 53.1 | 69.0 |
|
Profit Attributable to Parent
|
18.2 | -39.6 | 28.6 | 53.1 | 69.0 |
|
Earnings per Share
|
1,139.00 | -2,475.00 | 1,545.00 | 2,538.00 | 4,313.30 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.